Ernst Lab published this week in @Els_Vaccine:
“BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice” by Sherman et al.
@ImmunologyNews @ElsevierNews
#vaccineresearch #immunology
Read more here: doi.org/10.21203/rs....
doi.org
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
Shigella spp. infection contributes significantly to the global disease burden, primarily affecting young children in developing countries. Currently, there are no FDA-approved vaccines against Shigel...